Opus Genetics, Inc.IRDEarnings & Financial Report
Nasdaq
NextMar 31, 2026
IRD Q3 2025 Key Financial Metrics
Revenue
$3.1M
Gross Profit
N/A
Operating Profit
$-8.3M
Net Profit
$-17.5M
Gross Margin
N/A
Operating Margin
-269.9%
Net Margin
-566.9%
YoY Growth
-20.4%
EPS
$-0.25
Financial Flow
Opus Genetics, Inc. Q3 2025 Financial Summary
Opus Genetics, Inc. reported revenue of $3.1M for Q3 2025, with a net profit of $-17.5M (-566.9% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $3.1M |
|---|---|
| Net Profit | $-17.5M |
| Gross Margin | N/A |
| Operating Margin | -269.9% |
| Report Period | Q3 2025 |
Opus Genetics, Inc. Annual Revenue by Year
Opus Genetics, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $11.0M).
| Year | Annual Revenue |
|---|---|
| 2024 | $11.0M |
| 2023 | $19.0M |
| 2022 | $39.9M |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.7M | $1.7M | $1.1M | $3.9M | $4.3M | $4.4M | $2.9M | $3.1M |
| YoY Growth | -95.8% | -2.2% | -69.7% | -67.6% | 154.4% | 155.4% | 159.2% | -20.4% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $53.9M | $51.8M | $44.8M | $40.4M | $36.9M | $48.2M | $38.7M | $36.1M |
| Liabilities | $4.0M | $5.8M | $4.2M | $6.1M | $11.3M | $24.3M | $21.2M | $30.2M |
| Equity | $49.9M | $46.1M | $40.6M | $34.3M | $6.7M | $5.1M | $17.5M | $6.0M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $4.5M | $-5.7M | $-7.3M | $-5.1M | $-7.4M | $-9.0M | $-10.3M | $-6.2M |